Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some investors are asking for a dividend
I agree. Buy back shares, 40 million of them in concert with Swartz and company departing the scene.
Share
New Message
Please login to post a reply